Former Director at Stemirna Therapeutics Co Ltd
- LNP (lipid nanoparticle), LPP (lipopolyplex) and LPX (lipoplex) delivery systems – technology routes and advantages and disadvantages
- Domestic vs foreign players in technology platform, pipeline planning and R&D progress
- China’s mRNA vaccine development progress and clinical research challenges
- Talent shortage in China and domestic players’ team competency comparison
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.